| Non-recipients of beta blockers | Carvedilol recipients | Selective beta blocker recipients | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | OR | 95% CI | p-value | |
Odds ratio for mortality in patients with vs. those without hypoglycemia (< 3.9 mmol/L) within 24 h of admission | |||||||||
 Unadjusted model | 2.40 | 1.56–3.71 | < 0.001 | 0.83 | 0.25–2.81 | 0.77 | 1.60 | 0.74–3.46 | 0.23 |
 Adjusted model | 2.10 | 1.15–3.86 | 0.016 | 0.79 | 0.15–4.10 | 0.78 | 1.67 | 0.54–5.16 | 0.37 |
Odds ratio for mortality in patients with vs. those without hypoglycemia (< 3.9 mmol/L) overall | |||||||||
 Unadjusted model | 2.21 | 1.60–3.04 | < 0.0001 | 1.18 | 0.54–2.60 | 0.68 | 2.17 | 1.08–4.37 | 0.03 |
 Adjusted model | 1.80 | 1.16–2.80 | 0.009 | 1.55 | 0.49–4.95 | 0.46 | 4.89 | 1.76–13.56 | 0.002 |
Odds ratio for mortality in patients with vs. those without hypoglycemia (< 2.2 mmol/L) overall | |||||||||
 Unadjusted model | 4.63 | 2.52–8.52 | < 0.0001 | 1.76 | 0.40–7.67 | 0.45 | 6.42 | 2.73–15.1 | < 0.0001 |
 Adjusted model | 3.74 | 1.48–9.46 | 0.005 | 1.94 | 0.36–10.3 | 0.44 | 10.6 | 3.27–34.3 | < 0.0001 |